Skip to main content
WAT
NYSE Industrial Applications And Services

Waters Corp's Acquisition Financing: $4 Billion Term Loan Secured for Reverse Morris Trust with BD SpinCo

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$393.68
Mkt Cap
$23.443B
52W Low
$275.05
52W High
$423.56
52W Position info
43% above low
Off High info
7.1% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

WAT sits 43% above its 52-week low of $275.05.

Summary

Augusta SpinCo Corporation, a subsidiary of BD, secured a $4 billion term loan facility to finance a cash distribution to BD as part of its Reverse Morris Trust transaction with Waters Corporation, significantly increasing the combined entity's debt.


Key Events · M&A and Partnerships · WAT

  • $4 Billion Term Loan Secured

    Augusta SpinCo Corporation, a subsidiary of BD, entered into a Term Loan Credit Agreement for up to $4 billion.

  • Financing for Reverse Morris Trust

    The loan will finance a cash distribution to BD in connection with the pending combination of BD's Biosciences and Diagnostic Solutions business with Waters Corporation.

  • Loan Structure and Maturity

    The facility includes a $3.5 billion Tranche 1 loan maturing in 364 days and a $500 million Tranche 2 loan maturing in two years.

  • Financial Covenants Established

    Post-acquisition, the combined entity will be subject to a maximum Leverage Ratio of 3.50:1.00 (with a temporary increase to 4.25:1.00 after the acquisition) and an Interest Coverage Ratio of at least 3.50:1.00.


Analysis · WAT · Industrial Applications And Services

This filing details a critical financing step for Waters Corporation's pending Reverse Morris Trust transaction with BD's Biosciences and Diagnostic Solutions business. The $4 billion term loan, secured by Augusta SpinCo (the entity being spun off from BD and then merged with Waters), represents a substantial financial obligation for the combined company. The primary use of these funds is to make a significant cash distribution to BD, the seller, which will increase the debt burden on the combined entity's balance sheet. While securing such a large facility ensures the execution of the strategic transaction, the associated debt load and financial covenants will be a key area of focus for investors, potentially impacting future financial flexibility and earnings. The short-term nature of Tranche 1 (364 days) suggests a plan for refinancing this portion quickly.

At the time of this filing, WAT was trading at $393.68 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $23.4B. The 52-week trading range was $275.05 to $423.56. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WAT - Latest Insights

WAT
Jul 27, 2026, 8:10 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $376.11
Real-time Price: $373.36 info
Change: -$2.75 (-0.73%) info
Market Cap: $37.694B info
WAT
Jun 08, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $377.51
Real-time Price: $373.36 info
Change: -$4.15 (-1%) info
Market Cap: $37.694B info
WAT
Jun 03, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $378.16
Real-time Price: $373.36 info
Change: -$4.80 (-1%) info
Market Cap: $37.694B info
WAT
Jun 01, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $383.73
Real-time Price: $373.36 info
Change: -$10.37 (-3%) info
Market Cap: $37.694B info
WAT
May 12, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $352.21
Real-time Price: $373.36 info
Change: +$21.15 (+6%) info
Market Cap: $37.694B info